Send feedback

ALK p.Arg1275Gln

c.3824G>A · rs113994087 · VCV18083

Pathogenic Multiple submitters
Classification
Pathogenic
ClinVar
Review
Multiple submitters ★★☆☆
ClinVar · 10 submitters
AlphaMissense
likely pathogenic
0.9906 · ACMG-weighted
gnomAD v4.1
Absent
absent from gnomAD v4.1
Missense predictors
3/3 damaging
AlphaMissense, REVEL, SaProt
Conditions
2
hereditary neoplastic syndrome

Computational evidence

Protein change
AlphaMissense0.9906likely pathogenic ✓ concordant with ClinVar · top 9% in ALK
REVEL0.885moderately pathogenic-leaning
SaProtLLR -14.26damaging
⇒ AlphaMissense, REVEL and SaProt all call this damaging.
Splicing
SpliceAI—not assessed · no allele here is in the release
Constraint at this position
ConservationphyloP 7.7GERP 2.4, phastCons 1
Regional constrainto/e 0.59unconstrained · MANE · 16 kb · p 1.6e-06 · regional, not allelic
Overall
CADD33.0PHRED · no single calibrated threshold — expert panels disagree

AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.

Population frequency

gnomAD v4.1 · exomes + genomes

Absent from gnomAD v4.1. Not observed in any sequenced alleles — a rarity signal (ACMG PM2-supporting), not evidence of pathogenicity on its own.

Cancer therapy — CIViC

DiseaseTherapiesLevelSignificance
NeuroblastomaCrizotinibCSensitivity/Response
NeuroblastomaCrizotinibCSensitivity/Response
NeuroblastomaLorlatinibDSensitivity/Response
NeuroblastomaCrizotinibDSensitivity/Response
NeuroblastomaCrizotinibBSensitivity/Response
NeuroblastomaALK Inhibitor TAE684DSensitivity/Response
NeuroblastomaALK Inhibitor TAE684DResistance
NeuroblastomaBPredisposition

Variant & gene context

Gene
ALK
Protein
p.Arg1275Gln
Coding
c.3824G>A
MANE Select
NM_004304
dbSNP
rs113994087
Type
single nucleotide variant
Location
chr2:29209798 (GRCh38)
Gene constraint
LOEUF 0.562 · pLI <0.01 · ClinGen HI 0/3 (gnomAD)
Structure
AlphaFold pLDDT 68.26 · 79 PDB
Residue 1275
an α-helix; a UniProt-annotated variant site (observed in neuroblastoma); a UniProt-annotated variant site (in nblst3; constitutively activated; retained in the endoplasmic reticulum and golgi compartments); the protein kinase domain
Full ALK gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Similar variants

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/alk-p-arg1275gln (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown